Stents and going with the flow

January 31, 2005

A stent is a wire mesh tube used to prop open an artery and improve blood flow to the heart muscle. In recent years drug-eluting stents have been developed, which, as the name suggest, are coated with drugs that are slowly released and help keep the artery from reclosing, an occurrence known as restenosis.

In the first of three articles on sirolimus-eluting stents, in the February 1 issue of CMAJ, Yang and Moussa explain the mechanism of action of these types of stents and the clinical and scientific rationale behind their use within a wider context of interventional cardiology.

In a related article, Shrive and colleagues evaluate the economic impact of sirolimus-eluting stents given their high cost and widespread use and report they are cost-effective when used in patients at increased risk of restenosis or at high risk of death if another revascularization procedure were to be performed.

Otherwise, state the authors, their use is associated with a cost per quality-adjusted life-year that is similar to or higher than that of other accepted medical forms of treatment and carries a high incremental cost.

In a related commentary, Brophy calculates that sirolimus-eluting stents could consume $75 million of our health care budget. Given the inconclusive evidence on efficacy and long-term benefits of sirolimus-eluting stents and the limited budgets, Brophy suggests that increased alternative investments in more basic primary and secondary prevention and treatment programs could be a more prudent approach.
p. 323 Percutaneous coronary intervention and drug-eluting stents
-- Y.-M. Yang, I. Moussa

p. 345 Economic evaluation of sirolimus-eluting stents
-- F.M. Shrive et al

p. 361 The dollars and sense of drug-eluting stents
-- J.M. Brophy

Canadian Medical Association Journal

Related Stents Articles from Brightsurf:

3D printed stents that treat inflammation
POSTECH Professor Dong-Woo Cho's research team develops bioink-loaded esophageal stents for treating radiation esophagitis.

Study could be first step in providing personalized care to patients with ureteral stents
Published today in Cell Reports Medicine, researchers at Lawson Health Research Institute and Western University conducted a novel microbiome study to examine bacteria associated with ureteral stents.

Two paths better than one for treating patients with heart stents
Pairing a blood-thinning drug with aspirin daily for patients who have an angioplasty with a stent can contribute to better health outcomes, including lower risk of death, than aspirin alone, according to a recent study by cardiologists at the University of Alberta and Mazankowski Alberta Heart Institute.

Open heart surgery outperforms stents in patients with multivessel disease
Coronary artery bypass grafting (CABG) surgery may be the best treatment option for most patients with more than one blocked heart artery, according to research published today in The Annals of Thoracic Surgery, published by Elsevier.

For infants with heart disease, are shunts or stents better to maintain blood flow?
Infants with various forms of congenital heart disease require a stable source of blood flow to their lungs in order to survive until a more definitive operation can be performed.

3-D-printed polymer stents grow with pediatric patients and biodegrade over time
A new study demonstrates proof-of-concept for combining computational design and simulation tools with 3-D printing technology to produce self-expandable polymer stents that can grow with pediatric patients, are biodegradable, and require only a minimally-invasive procedure for implantation.

Cardiologist warns against dissolvable stents in NEJM
In a New England Journal of Medicine (NEJM) editorial published last week, Debabrata Mukherjee, M.D., provides expert commentary on bioresorbable stents, an alternative to the traditional stents used in patients with cardiac conditions.

A simple fix to avoid some unnecessary coronary stents
Physician researchers at Thomas Jefferson University suspect that some cases of coronary artery spasm go unrecognized and are incorrectly treated with stents.

For malignant biliary obstruction, plastic stents may be cost-effective alternative
Preoperative biliary drainage (PBD) with stent placement has been commonly used for patients with malignant biliary obstruction.

3-D printing customized vascular stents
Using high-resolution 3-D printing, Northwestern University researchers can create flexible, biodegradable stents on-demand that are customized for a patient's specific anatomy.

Read More: Stents News and Stents Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to